| 标题 |
SAT0240 Phase 3 trial results with blisibimod, a selective inhibitor of B-cell activating factor, in subjects with systemic lupus erythematosus (SLE) |
| 网址 | |
| DOI | |
| 其它 |
期刊:Annals of the Rheumatic Diseases 作者:Joan T. Merrill; RS Martin; WR Shanahan; Morton Scheinberg; Kenneth Kalunian; et al 出版日期:2017-06-01 |
| 求助人 | |
| 下载 | 该求助完结已超 24 小时,文件已从服务器自动删除,无法下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)